Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Pharma
Sanofi wins FDA okay with first GD3 drug to treat neuro decline
Sanofi's Infilbray is the first FDA approved therapy to address the neurological effects of Type 3 Gaucher disease.
Donavyn Coffey
Nov 20, 2026 9:30am
Sanofi mulls buyout of Insmed and its Brinsupri: Bloomberg
Nov 19, 2026 2:10pm
AI’s Real Prize: Building Tomorrow’s CI Capability
Brought to you by
Eradigm
Novartis stares down $16.7B post-2030 patent cliff
Nov 19, 2026 11:45am
Digital Twins: Advancing Clinical Evidence Strategy
Brought to you by
IQVIA
Arcera floats $1B+ total to license Innogen's GLP-1 beyond China
Nov 19, 2026 11:30am